Clinicopathological Features of 15 Occult and 178 Clinical Pancreatic Ductal Adenocarcinomas in 8339 Autopsied Elderly Patients

Objective The aim of the study was to investigate the clinicopathological features of pancreatic cancer at different stages using autopsy results. Methods We retrospectively evaluated 8399 consecutive cases of autopsy performed between 1972 and 2013 at our geriatric hospital. Results Macroscopic pancreatic lesions were detected in 6.13% of the cases. Primary and secondary pancreatic tumors were observed in 2.88% and 2.10% of the cases, respectively. Most primary tumors were invasive ductal adenocarcinomas (193 cases [2.31%]; mean patient age, 78.09 years) with a peak incidence at 50 to 59 years. Occult invasive ductal adenocarcinoma was discovered incidentally in 15 cases, with distant metastasis present in 26.67% of those. Microscopically, occult and advanced tumors exhibited similar characteristics such as hyalinized fibrous stroma, necrosis, invasion into vessels, peripancreatic fat tissues, and extrapancreatic nerve plexus. Mucin 1 and 2 immunohistochemical expression levels were also similar. Occult cancer incidence increased with age. Patients aged 85 years or older had shorter survival, a small tumor size, and a low incidence of lymph node metastasis. Approximately 8% of pancreatic invasive ductal adenocarcinomas progressed asymptomatically and were discovered incidentally at autopsy. Conclusions Pancreatic cancers in elderly patients tend to progress asymptomatically, but once symptoms develop, they are more often fatal than those in younger patients.

[1]  A. Abioye,et al.  Pancreatic carcinoma. , 2020, Journal of the National Medical Association.

[2]  Todd Gress,et al.  Pancreatic Cancer Survival in Elderly Patients Treated With Chemotherapy , 2014, Pancreas.

[3]  Simion I. Chiosea,et al.  KRAS mutant allele-specific imbalance is associated with worse prognosis in pancreatic cancer and progression to undifferentiated carcinoma of the pancreas , 2013, Modern Pathology.

[4]  F. Tas,et al.  Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival , 2013, Molecular and clinical oncology.

[5]  J. DeGregori,et al.  Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age? , 2013, Oncogene.

[6]  D. Serraino,et al.  Time trends of cancer mortality among elderly in Italy, 1970–2008: an observational study , 2012, BMC Cancer.

[7]  L. Qin,et al.  A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers , 2012, PloS one.

[8]  G. Eibl,et al.  Epidemiology, risk factors, and the promotion of pancreatic cancer: Role of the stellate cell , 2012, Journal of gastroenterology and hepatology.

[9]  M. Sawabe,et al.  [Pathologic characteristics of malignant neoplasms occurring in the elderly]. , 2011, Gan to kagaku ryoho. Cancer & chemotherapy.

[10]  T. Riall,et al.  415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival. , 2011, The Journal of surgical research.

[11]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[12]  Andrew Menzies,et al.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer , 2010, Nature.

[13]  Alison P. Klein,et al.  DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  K. Takubo,et al.  Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly , 2007, Pathology international.

[15]  Martin J Blaser,et al.  Infection, cancer and prevention: report of the 19th International Symposium of the Foundation for Promotion of Cancer Research. , 2006, Japanese journal of clinical oncology.

[16]  Mitch Leslie,et al.  The age of cancer. , 2006, Science of aging knowledge environment : SAGE KE.

[17]  D. Bergqvist,et al.  Trousseau’s syndrome – what is the evidence? , 2006, Thrombosis and Haemostasis.

[18]  T. Hwang,et al.  Adenosquamous Carcinoma of the Pancreas , 2005, Digestion.

[19]  M. Talamonti,et al.  Surgical management of pancreatic cancer. , 2005, Seminars in radiation oncology.

[20]  K. Kanazawa,et al.  Multiple colorectal cancers in the elderly: a retrospective study of both surgical and autopsy cases , 2001, Journal of Gastroenterology.

[21]  E. Paal,et al.  A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature. , 2001, Annals of diagnostic pathology.

[22]  K. Lillemoe,et al.  Pancreatic cancer: State‐of‐the‐art care , 2000, CA: a cancer journal for clinicians.

[23]  J. Howard,et al.  Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies. , 1995, Archives of surgery.

[24]  O. Dodge Tumours of the Pancreas , 1981, British Journal of Cancer.

[25]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[26]  Z. Naito,et al.  Report on Experiments and Clinical Cases ― Clinicopathological Features of 30 Autopsy Cases of Pancreatic Carcinoma , 2012 .

[27]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.